Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 36839

Diazene JK-279: potential anticancer drug


Osmak, Maja; Bordukalo, Tatjana; Jernej, Branimir; Košmrlj, Janez; Polanc, Slovenko
Diazene JK-279: potential anticancer drug // Anti-cancer drugs, 10 (1999), 9; 853-859 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 36839 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Diazene JK-279: potential anticancer drug

Autori
Osmak, Maja ; Bordukalo, Tatjana ; Jernej, Branimir ; Košmrlj, Janez ; Polanc, Slovenko

Izvornik
Anti-cancer drugs (0959-4973) 10 (1999), 9; 853-859

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
anticancer drugs; diazenes; tumor cells; drug-resistance

Sažetak
The aim of this study was to examine the cytotoxic effect of ten new synthesized diazenecarboxamides (diazenes). Using a modified colorimetric MTT assay, their cytotoxicity was determined on ten human cell lines: cervical carcinoma parental and cisplatin resistant cells, laryngeal carcinoma parental and cisplatin and vincristine resistant cells, glioblastoma parental and cisplatin resistant cells, breast adenocarcino-ma parental and doxorubicin resistant cells and mammary carcinoma cells. Results show that diazene JK-279 was most effective, reducing significantly the cell survival of all ten cell lines examined, including five drug-resistant cell lines. Cytotoxic effect was observed also on nine from ten cell lines for diazene JK-835. A small reduction in cell survival was obtained (mainly for highest drug concentrations) for diazenes LV-57 and MG-19 on two cell lines, and JK-429 and JK-913 on one cell line. Other diazenes did not demonstrate any cytotoxic activity. The results encourage further research on diazene JK-279 as a potential anticancer drug.

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Temeljne medicinske znanosti



POVEZANOST RADA


Projekti:
00981008
00980002

Ustanove:
Institut "Ruđer Bošković", Zagreb


Citiraj ovu publikaciju:

Osmak, Maja; Bordukalo, Tatjana; Jernej, Branimir; Košmrlj, Janez; Polanc, Slovenko
Diazene JK-279: potential anticancer drug // Anti-cancer drugs, 10 (1999), 9; 853-859 (međunarodna recenzija, članak, znanstveni)
Osmak, M., Bordukalo, T., Jernej, B., Košmrlj, J. & Polanc, S. (1999) Diazene JK-279: potential anticancer drug. Anti-cancer drugs, 10 (9), 853-859.
@article{article, author = {Osmak, Maja and Bordukalo, Tatjana and Jernej, Branimir and Ko\v{s}mrlj, Janez and Polanc, Slovenko}, year = {1999}, pages = {853-859}, keywords = {anticancer drugs, diazenes, tumor cells, drug-resistance}, journal = {Anti-cancer drugs}, volume = {10}, number = {9}, issn = {0959-4973}, title = {Diazene JK-279: potential anticancer drug}, keyword = {anticancer drugs, diazenes, tumor cells, drug-resistance} }
@article{article, author = {Osmak, Maja and Bordukalo, Tatjana and Jernej, Branimir and Ko\v{s}mrlj, Janez and Polanc, Slovenko}, year = {1999}, pages = {853-859}, keywords = {anticancer drugs, diazenes, tumor cells, drug-resistance}, journal = {Anti-cancer drugs}, volume = {10}, number = {9}, issn = {0959-4973}, title = {Diazene JK-279: potential anticancer drug}, keyword = {anticancer drugs, diazenes, tumor cells, drug-resistance} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Uključenost u ostale bibliografske baze podataka::


  • CC
  • SCI





Contrast
Increase Font
Decrease Font
Dyslexic Font